Angle claims FDA okay for Parsortix liquid biopsy system After more than six years of development, Angle has scored an FDA approval for Parsortix as a diagnostic for metastatic breast cancer – the ...
What Starts Here Changes the World. It's more than a motto. It’s what we prove each and every day, as Texas and its Exes advance discovery and innovation on a global stage. Join us. Honesty, integrity ...
Abstract: A photonics-based system for simultaneous time–frequency analysis and angle-of-arrival (AOA) measurement with reconfigurable frequency resolution has been introduced and experimentally ...
Abstract: The dwell scheduling problem for a multifunctional radar system is led to the formation of corresponding optimization problem. In order to solve the resulting optimization problem, the dwell ...
The first half of the decade (2025–2030) will witness a climb from USD 93.3 million to USD 165.2 million, contributing over 36% of decade-long growth. University laboratories, semiconductor R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback